Comment on: Possible miliary tuberculosis during adalimumab therapy with negative gamma-IFN release assays.
Mangat
Pamela
P
Taylor
Peter
P
Abraham
Sonya
S
D000068879:Adalimumab; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D003937:Diagnosis, Differential; D006801:Humans; D007371:Interferon-gamma / Q000096:biosynthesis*; D009164:Mycobacterium Infections / Q000175:diagnosis; D009894:Opportunistic Infections / Q000175:diagnosis*; D014391:Tuberculosis, Miliary / Q000175:diagnosis*
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D007371:Interferon-gamma; D000068879:Adalimumab